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ABSTRACT 
Since its recognition in 1981, the Acquired Immune Deficiency 
syndrome (AIDS) has been responsible for the deaths of at least 
23,884 of its victims. The causative agent, human immuno-
deficiency virus (HIV), is transmitted primarily via blood 
and semen. The virus acts by depressing the body's immune 
system, thereby making it subject to attack from a multitude of 
opportunistic infections and Kaposi's sarcoma. 
systemic infections result. 
Ocular and 
As primary health care professionals, optometrists' role in this 
battle against AIDS is one of detection, prevention and proper 
patient education. Recognizing the ocular manifestations of AIDS 
may facilitate the diagnosis. Early detection could mean more 
prompt treatment and a better prognosis for the AIDS patient. 
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AIDS .•• the Plague of the 80's. This statement reflects the 
widespread hysteria which has swept America. What is the nature 
of.this disease which has attracted so much attention? 
AIDS is an acronym for Acquired Immune Deficiency syndrome. The 
name appropriately describes the condition: "acquired" means it 
is associated with the environment and is not inherited; "immune" 
relates to the body's innate ability to ward off disease; 
"deficiency" refers to a breakdown in this ability to defend 
against disease; "syndrome" represents specific signs and 
symptoms which collectively characterize a disorder.l A person 
with this syndrome was defined in 1982 by the Centers for Disease 
Control (CDC) as one with a compromised immune system and certain 
opportunistic infections or cancers without any underlying 
cause.2 This definition was revised in 1985 and included several 
other diseases occurring along with a positive 
serologic/virologic HTLV-III/LAV test. 
There is a fine line between AIDS and what is known as Aids 
Related Complex (ARC). The difference is a matter of degree. A 
patient with AIDS has a more life-threatening condition and has 
at least one serious opportunistic infection or Kaposi's sarcoma 
as described by the CDC definition.3 On the other hand, ARC is 
less serious and is characterized by one or more of the following 
symptoms for more than three months: 
Fever and night sweats 
Weight loss greater than 10% of body weight, 
or 15 pounds 
Generalized swollen glands 
Chronic diarrhea 
Abnormal lab findings3 
It is controversial at this time as to what percentage of 
individuals with ARC will develop AIDS, although some 
- 2 -
investigators believe it is high. 
EPIDEMIOLOGY 
As of December 1987, 47,436 cases of AIDS have been reported with 
at least 27,235 (57%) resulting in death.4 It is estimated that 
another 500,000 to 1 million individuals in the u.s. carry the 
virus without a diagnosis of AIDS or ARC. Yet they are 
considered capable of infecting someone else.5 
The incidence of AIDS has dramatically increased since it was 
first recognized in 1981.6 Until just recently when a slight 
decline was noticed, the number of AIDS cases was doubling every 
year. Presently in the United States, AIDS is considered to be 
the leading cause of death among young men. It is estimated 
that more than 270 1 000 new cases will develop into AIDS by 1991, 
14,000 of these occurring in 1991 alone.7 
The distribution of the disease is worldwide.6 Estimates of 
worldwide infection run as high as 10 million.? AIDS has been 
reported in all 50 USA states, the District of Columbia and 3 USA 
territories, in addition to at least 16 European countries and 
other nations. In the u.s. most cases are clustered in major 
urban areas with more than half residing in New York City, New 
Jersey, California, Florida and Texas. 
In the u.s. 60% of AIDS patients are white, 25% black and 14% 
Hispanic.l Of thesej 7% are womenl and 90% are between the ages 
of 20 and 49.6 since screening of all military applicants by our 
Armed Services in 1985 became mandatory, the ratio of infected 
men to women was found to be 2.5:1.7 Although the AIDS virus is 
trasmitted without regard to sex, social class, age or race, some 
individuals are at greater risk than others to contract the 
disease. 
\., 
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ETIOLOGY 
It is believed that the AIDS virus infection originated in 
central/eastern Africa was transmitted to man from the green 
monkies (Cecopithecus Aethiops). These monkies are unlike man 
in that they have an internal mechanism which can control the 
virus so that its immune system is not affected.8 The virus came 
to America in the late 1970's and was formally recognized by the 
CDC in June 1981. The "cause" of the disease at that time was 
unknown and defined only by its symptoms. 9 It was not until 
1984 that the causative agent of AIDS was discovered and 
identified as human T-cell lymphotrophic virus type III 
/lymphadenopathy-associated virus, otherwise known as 
HTLV-III/LAv.lO This particular virus is a member of the 
retrovirus family: a group known for its virulence, endurance 
and classified as one of its most harmful strains.3 
The virus' genetic code is in the form of RNA rather than DNA. 
It mainly attacks T-helper lymphocytes and nerve tissue. It 
transforms the T-helper lymphocytes into a form that the body is 
unable to recognize and suppresses ordinary distress signals 
which protect the virus-infected cell from being attacked. 
Eventually, massive viral replication occurs and kills the host 
cell.7 
Lymphocytes are broken up into two categories: B-cells and 
T-cells. The B-cells manufacture antibodies in response to a 
foreign substance or antigen and the T-cells monitor the B-cells' 
activity. The T-cells are further divided into T-helper and 
T-suppressor cells. The T-helper cells are the master 
controllers of the body's immune system and activate the B-cells 
when an antigen is present. T-suppressor cells limit immune 
attack through negative feedback and can prevent attacks against 
healthy cells.? 
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Attack of the T-helper lymphocytes by HIV inhibits the body's 
immune system from properly responding to an antigen. The 
B-cells are not activated to produce adequate amounts of 
antibodies against an antigenic attack and the supply of 
T-suppressor cells becomes so abundant that the entire immune 
system shuts down. Due to this chain of events, the entire body 
becomes vulnerable to attack by a wide array of opportunistic 
infections.? 
TRANSMISSION 
There has been a lot of concern and hysteria over the contraction 
of AIDS through casual contact. There has been no documented 
cases to date whereby an individual contracted AIDS through 
touching, hugging or breathing the air near someone who is 
infected. "Aids is spread by sexual contact, intravenous-drug 
use with contaminated needles or syringes, and, less commonly, 
through transfused infected blood or blood products, and from an 
infected mother to her baby in the womb or during birth."l There 
is no evidence that mosquitos, ticks and other insects can 
transmit AIDS.6 
The most common mode of transmission is through an activity which 
exposes mucous membranes or the blood stream to infected blood or 
semen.l The virus has been isolated in blood, semen, saliva, 
breast milk, urine, pulmonary secretions, lymph nodes, brain 
capillary endothelial cells, brain tissue, cerebrospinal fluid, 
bone marrow, cell free plasma, cervical and vaginal secretions, 
tears and corneal and conjunctival tissues.6 Although 
HTLV-III/LAV has been isolated in the tears and ocular tissues of 
AIDS patients, these routes have yet to be linked to the 
development of any individual cases of AIDs.7 Although there is 
currently no documentation of transmission of the virus after 
corneal transplantation, serologic screening of potential cornea 
donors see~~ justified.ll 
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Not everyone exposed to the virus will contract AIDS. In 
addition to exposure, there are unknown co-factors which make one 
individual more susceptible to develop symptoms than another. 
Of those who become infected, some patients may remain healthy 
with their immune system little affected. Most develop a 
seemingly peaceful co-existence with the virus.2 It is difficult 
to assess the actual risk of transmission of the virus, though, 
due to the variable latency period of the virus ranging from 4 
months to 7 years.6 
RISK GROUPS 
It is important for the clinician to be aware of these high-risk 
groups so he is alerted to certain signsjsymptoms the patient may 
present with. These high-risk groups by percentage of incidence 
are: 
73% - homosexual or bisexual men 
17% - intravenous-drug abusers 
1% - hemophiliacs 
1% - transfusion recipients 
1% - heterosexual contacts12 
The remaining 7% do not belong to any of these risk groups. 
Previously, recent Haitian immigrants were recognized as a 
distinct risk group, making up 3% of this unknown risk group.12 
However, they were removed from the list when it became apparent 
that cases among Haitians were linked with the same risk 
behaviors as other cases - sexual contact, sharing of needles and 
blood transfusions.! 
' ~ 
Revised statistics released by the CDC suggest that the 
percentage of AIDS patients is dropping in homosexual and 
bisexual men but rising in heterosexual and intravenous-drug 
abusers. This trend probably reflects the movement of HIV into 
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a new segment of the population.5 The number of new cases of 
heterosexually transmitted AIDS infection has been predicted 
to increase nearly sevenfold by 1991 and is presently increasing 
two times as fast as the number of homosexually transmitted 
cases. In fact, it has been found that if one partner of a 
married couple was exposed to the virus, there's a 40-50% chance 
that the other partner would also become infected.? 
In addition to sexual partners of members belonging to a 
high-risk group, the newborn of an infected mother is also at 
great risk. The newborn has about a 50% chance of contracting 
the disease. The likelihood of transmission increases with each 
successive pregnancy. In addition, the stress than often 
accompanies a pregnancy can convert an asymptomatic infection in 
the mother into the full-blown syndrome.l 
SYSTEMIC MANIFESTATIONS 
Besides examining the eyes, the optometrist should always be 
aware of the patient's general health. The following signs and 
symptoms are not diagnostic of AIDS. However, patients 
displaying them, especially those in high risk groups, should be 
referred to a physician who is knowledgeable in AIDS. 
1) Lymphadenopathy: Persistent, enlarged, hardened and painful 
lymph nodes for more than 3 months in any 2 or 3 locations. 
2) Recent onset of slowly enlarging purplish or discolored 
lump~, rashes or new growths on the skin or mucous 
membranes. This includes under the eyelids. 
3) Thrush: A whitish coating on the tongue or throat which is 
caused by a fungus (Candida albicans) and/or raised areas 
on the lateral surfaces of the tongue not attributed to 
steroid and antibiotic therapy. 
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4) Herpes Zoster not related to stress. 
5) Anorexia: Weight loss greater than 10 pounds in less than 2 
months without apparent reason. 
6) Persistent night sweats or fever. 
7) A lingering dry cough with shortness of breath unrelated to 
smoking, a cold or the flu. 
8) Frequent episodes of diarrhea. 
9) Easily attained bruises or unexplained bleeding from 
openings on the body. 
10) Persistent extreme fatigue often accompanied with light 
headedness or a headache, unrelated to physical/mental 
stress, depression or medications. 
11) Persistent loss of memory, changes in equilibrium, hearing, 
smell and taste and periodic blurring or vision loss. The 
patient may also experience mood swings or neurological/ 
psychiatric symptoms. 
12) Recurrent pain of unknown etiology.6 
\.. 
In addition to these signs and symptoms, we must also be aware of 
the systemic ''manifestation called Pneumocytis Carinii Pneumonia 
(PCP). At present, PCP is the most common opportunistic 
infection in patients with AIDS and its incidence is increasing 
with respect to other opportunistic diseases. The Pneumocystic 
carinii, a protozoan, often causes pneumonia which usually lasts 
longer in patients with AIDS. In general, patients in high risk 
groups who diplay respiratory illness and pulmonary infiltrate 
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without leukocytosis, run a high chance of having PCP.6 
OCULAR MANIFESTATIONS 
Ocular legions occur with high frequency in patients with known 
Acquired Immune Deficiency Syndrome.13 Investigators have 
reported that the prevalence of abnormal ocular findings in AIDS 
patients ranges between 53% and 73%. Although many have 
extensive ocular abnormalities, they rarely have ocular 
symptoms.14 
Palestine et al separated the ocular pathology into four major 
categories: Cotton-wool spots, Cytomegalovirus retinitis, 
conjunctival Kaposi's sarcoma and neuro-opthalmic motility 
abnormalities.2 These categories represent the most common 
ocular manifestations. However, due to the great variety of 
opportunistic infections and cancers that occur in AIDS, the 
range of ocular manifestations has been reported to also include 
the following: conjunctivitis due to cytomegalovirus, herpes 
simplex retinitis, herpes zoster opthalmicus, retinal 
periphlebitis, keratoconjunctivitis sicca, acute retinal 
necrosis, optic neuritis, keratitis, choroidal granulomas, 
cryptococcus retinitis, toxoplasmosis retinitis, mycobacterium 
avium intracellulare retinitis and ocular candidiasis.2,13,14 
None of these ocular disorders associated with AIDS is known to 
be a direct result of Hiv.15 
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OCULAR VASCULAR ABNORMALITIES 
COTTON-WOOL SPOTS 
Cotton-wool spots are the most frequently observed AIDS-related 
retinopathy, occurring in more than 50% of patients with AIDS.6 
The high incidence of this ocular finding can be a very important 
sign the clinician can use to recognize the syndrome. 9 These 
fluffy white patches are observed most commonly near the optic 
nerve head and in the posterior pole, and they can obscure the 
underlying vessels.2 
clinical trace.6 
They resolve in 4-6 weeks, leaving no 
The lesions are caused by ischemia which is attributed to damaged 
retinal capillaries.l5 The cause of the capillary damage is 
still unknown, although there are several speculations. In 
patients with AIDS, it is believed that increased levels of 
circulating immune complexes deposit in the vasculature with 
resultant ischemia, 
spot formation.l3 
stasis of axoplasmic flow and cotton-wool 
Newsome et al agree with this but also 
offer as potential causes the toxic effect of a viral agent on 
the vascular endothelium and increased blood viscosity leading to 
coagulation and flow problems.2 
RETINAL HEMMORHAGES 
Retinal hemo,rrhages are less frequently observed signs of this 
vascular di~order.l5 They may occur concurrently with 
cotton-wool spots.2 The presence of retinal hemorrhages and 
cotton-wool spots do not reflect the severity of the underlying 
disease.l6 Both may appear and disappear spontaneously during 
the course of the disease.~ They cause few, if any, ocular 
symptoms2 and are believed to be non-infective.5 However, once 
the blood-retinal barrier is broken, opportunistic organisms are 
free to enter and destroy retinal tissue and may cause serious 
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visual impairment in a matter of weeks.5 
CONJUNCTIVAL ABNORMALITIES 
Another vascular abnormality involves the conjunctival vessels. 
These vessels, usually venules, are coma-shaped or aneurysmal in 
the AIDS patient. They may occur in isolation or may be 
continuous with narrowed conjunctival vessels. 75% of AIDS or 
ARC patients were found to exhibit this finding which was always 
observed to be bilateral.6 
KAPOSI 1 S SARCOMA 
Kaposi's sarcoma is a rare malignant vascular tumour10 which can 
affect the skin, mucous membranes and internal organs such as the 
liver and lung.17 Prior to its association with AIDs; in the 
u.s. Kaposi's sarcoma usually affected elderly men of European 
descent. It was known as a rare and indolent form of malignant 
neoplasm.13 
In AIDS patients, an aggressive form of Kaposi's sarcoma has been 
described with a poorer prognosis. Kaposis's sarcoma is usually 
not the cause of death (20% mortality rate for Kaposi's sarcoma 
alone)17 unless there is visceral involvement.2 It appears that 
patients with Kaposi's sarcoma alone have the best longterm 
prognosis, with an average of 125 weeks survival rate.6 
Kaposi's sarcoma is the presenting ocular manifestation of AIDS 
in 24% of ,_all reported cases .17 ocular involvement usually 
occurs as ~onjunctival nodules and eyelid lesions.1 3 The 
conjunctival·,- nodules may look very similar to subconjunctival 
hemorrhages, melanomas or hemangiomas10 and may make diagnosis 
difficult. on the skin the lesion is characteristically an 
enlarging bluish-brown plaque or nodule and is often hemor-
rhagic.17 These lesions do not threaten vision or cause any 
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discomfort.lO 
NEURO-OPTHALMIC ABNORMALITIES 
Another disorder which strikes AIDS victims is AIDS encepha-
lopathy. Only about 5% of people dying with AIDS have 
histologically and pathologically normal brains upon exam-
ination. About 40% have focal infections and the remainder 
have a diffuse chronic degenerative encephalitis.2 
Due to lesions of the visual or oculomotor pathways, AIDS 
patients may experience diplopia, extraocular motility deficits, 
pupillary abnormalities, visual field loss, papilledema and 
blurring of vision.6,15,17 Patients may also complain of visual 
hallucinations of both the formed and unformed type due to 
lesions in the cerebral cortex. Many of the neuro-opthalmic 
disorders of brain origin may occur with CSF changes and before 
any changes are evident radiologically in the brain.6 Therefore, 
ocular motilities, pupillary reflexes and visual fields should 
be performed on all patients and detection of a disorder in an 
AIDS patient or suspect should herald CT scan and CSF 
evaluations.l9 
OPPORTUNISTIC INFECTIONS 
CYTOMEGALOVIRUS 
Opportunistic infections of the eye - bacterial, viral, fungal 
and parasitic - are the most serious opthalmic complication in 
'\·, 
the AIDS patient. Cytomegalovirus (CMV) causes the most common 
opportunistic infection in AIDS, affecting between 25% to 45% of 
these patients.l5 It is the most common cause of visual loss in 
the AIDS patient. cotton-wool spots often preceed the appearance 
of CMV retinitis, although the area involved is not necessarily 
where the cotton-wool spots were. 
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CMV is a member of the herpes family. Most adults have been 
exposed to CMV during their lifetime, with 50% to 100% showing 
CMV sensitivity.2 But the virus causes no serious disease in 
healthy individuals.15 Prepose et al suggest that CMV infection 
and spread in the retina occurs when the blood-ocular barrier 
breaks down due to immune complex deposition and resultant 
vascular endothelium damage.? Fluorescein angiography reveals 
retinal vascular occlusions and areas of retinal non-perfusion. 
Choroidal fluorescence is also diminished, suggesting that the 
process extends to this level. Microaneurysms may be observed 
along dilated vessels in necrotic areas.6 
CMV retinitis may be the initial clinical presentation of a 
patient with AIDS. Early CMV retinitis lesions appear as dry, 
white, granular areas of opacification adjacent to major retinal 
vessels. The early lesions are often difficult to differentiate 
from cotton-wool spots.2 Opthalmoscopically, the early CMV 
retinitis lesion has a more grainy and dense appearance in 
contrast to the more fluffy appearance of cotton-wool spots. 
In addition,,, CMV lesions lie deeper than do cotton-wool spots 
and they remain visible, whereas cotton-wool spots can fade 
quickly.14 
These CMV retinitis lesions can occur in either the posterior or 
peripheral retina.13 Patients with peripheral retinitis will 
have normal visual acuity but inflammation of the vitreous gel 
may result in complaints of floaters.6 Involvement of the optic 
nerve, in contrast, will produce a marked decrease in visual 
acuity.16 
As the infection progresses, the lesions produce prominent 
sheathing of retinal vessels. Larger areas of retinal and 
choroidal inflammation, necrosis, retinal hemorrhages, exudates 
and exudative retinal detachments are observed. The eventual 
outcome is total retinal atrophy and blindness.2 CMV infection 
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is relentlessly progressive in the AIDS patient over a period of 
months without undergoing spontaneous remission.19 The prognosis 
is poor, with most patients dying within 6 to-, 8 weeks of the 
appearance of the reinitis.2 The clinician can monitor the 
progress of the retinitis with visual field~ and fundus 
photographs.19 
FUNGAL INFECTIONS 
The AIDS patient is also at risk for developing an opportunistic 
fungal infection.22 There have been a few isolated cases of 
Cryptococcal choroiditis reported. Candida retinitis is 
infrequently seen in association with AIDS but may occur in AIDS 
patients who are intravenous drug abusers. Early lesions may 
resemble cotton-wool spots with fluffy borders and may range in 
size from less than one to several disc diameters. Fungal 
endopthalmitis is characterized by small white-yellow retinal 
infiltrates.6 
As time progresses, satellite lesions may develop. Untreated, · 
the lesions increase in size and the process spreads to the 
vitreous resulting in choroid-vitreous haze, vitreous abscesses 
and retinal detachment. Luckily, vitreous involvement is a late 
feature.6 
Mycotic corneal ulcers are one of the more rare ocular 
manifestations which occur in association with AIDS. Parrish 
et al and Santos and co-workers all describe spontaneous fungal 
corneal ulcers occurring in patients with AIDS or ARc.22 
TOXOPLASMOSIS 
Ocular toxoplasmosis associated with AIDS is very rare, although 
nonocular disseminated toxoplasmosis is not.23 It typically 
presents as a focal necrotizing retino-choroiditis with an 
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accompanying vitreitis.24 The patient may present with 
complaints of blurred vision and floaters. The intraretinal 
lesions are typically white-yellow in color, slightly raised, and 
with irregular borders. There is little or no anterior uveitis, 
and resolution leaves a pigmented, often irregular scar. The 
active lesion usually occurs at the border of an old active 
scar. The lesions may cause a branch retinal artery occlusion if 
they encompass retinal arterial branches.6 
If the lesion is present in the macula, papillomacular bundle or 
optic nerve head, significant permanent loss of vision may 
occur. In the imunocompetent person with'toxoplasmosis 
retinochoroiditis, vision returns to normal once,_the vitreous 
clears so long as the lesions did not involve a vital area. 
Recurrent attacks may occur with accompanying pain, photophobia, 
redness, vitreous floaters and decreased vision. A more 
aggressive form of toxoplasmosis occurs in the immunosuppressed 
individual with central nervous system, visceral and lymph node 
infections.6 
TUBERCULOSIS 
A high incidence of tuberculosis is found in areas in which AIDS 
is prominent.6,25 The HIV virus seems to reactivate the latent 
M. tuberculosis infection and cause the AIDS victim further 
health problems.6 
In the eye, there is a possibility that extrapulmonary 
tuberculosis may exist in AIDS patients if miliary tubercles are 
found in the choroid. A study showed that an AIDS victim at' 
death displayed signs of both extrapulmonary tuberculosis and 
ocular manifestations.25 In general, deaths among patients with 
both extrapulmonary TB and AIDS have increased, especially in 
high risk areas.6 
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HERPES ZOSTER OPHALMICUS AND HERPES SIMPLEX VIRUS 
There seems to be a strong correlation between Herpes zoster 
infection and immunosuppression, especially in the younger age 
groups. Persons treated with local irradiation or 
immunosuppressive drugs and patients with malignant neoplasms 
show a high incidence of Herpes zoster.26 A two year study found 
that Herpes zoster opthalmicus along with a high incidence of 
ocular disorders occurred in a small adult population who 
were young, presented AIDS risk factors, showed diminished 
T-helper cell subpopulations and an increase in gamma-globulin.27 
Herpes zoster opthalmicus is defined by a vesi.culbullous rash 
which follows the opthalmic branch of the trige~inal nerve and 
may also include conjunctivitis, keratitis, blepharitis and 
uveitis.6, 27 
Therefore, Herpes zoster in AIDS risk patients seem to be an 
early clinical sign for the immune deficiency created by the AIDS 
retroviral infection.27 
Herpes simplex infection has also been found in the eye of AIDS 
victims.27 Viral antigens of Herpes simplex were demonstrated in 
all retinal layers, retinal pigment epithelium and 
choriocapillaris. It seems to infect via viremic pathways 
rather than direct infection since the Herpes simplex does not 
appear in the optic nerves of persons with AIDs.6 
TREATMENT FOR SPECIFIC INFECTIONS 
At the present time, there is no generalized treatment for AIDS. 
The primary aspect of AIDS treatment deals with the individual 
management of the opportunistic infections and malignancies that 
the AIDS victims so often possess.6 
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The treatment of choice for Pneunocystis carinii is trimethoprim 
jsulfamethoxazole. However, side effects such as skin rash, 
lymphopenia and thrombocytopenia were shown in persons with 
AIDs.6 Ribavirin (Virazole) is also used to treat common 
pneumonia and is effective against the HIV virus in vitro.7 
Other alternative drugs being evaluated are pen~~madine given 
intravenously for 14-21 days, dapsone, tri-metrexate and alpha 
difluoromethylornithine (MFM0).6 
No curative treatment thus far, has been found for Kaposi's 
sarcoma. The drugs vincristine and alpha-2-interferon only 
showed a partial response in AIDS patients.6 Isolated lesions 
can be removed through simple excision or cryotherapy but when 
cutaneous involvement is extensive, chemotherapy is used. 2 
Kaposi's sarcoma in AIDS patients is radioresistant and responds 
variably to chemotherapy. 
Effective drug treatment for CMV is currently not available.? 
However, Dihydroxy propoxymethyl guanine (DHPG), a new acyclic 
nucleoside antiviral agent, is used to treat patients with CMV 
retinopathy.28 So far it has produced positive results with mild 
adverse side effects.29 Clinical studies showed that response to 
DHPG varied depending on the stage of the CMV but in general, it 
succeeded in stopping the progression of retinopathy. Signs of 
improvement included a decrease in retinal opacification, 
resolution of retinal hemorrhage and vasculitis, mobilization of 
necrotic tissue, minimal inflammatory reaction and reabsorption 
of edema fluid from the non-infected area near the retinopathy. 
Visual acuity also showed slight improvement and stability.30 
However, discontinued use of DHPG showed a relapse. Retinitis 
occurred and reoccurred at new and old lesions on the retina.30 
The problem with this drug is that it is only able to suppress 
the virus, not eliminate it. Clinical studies have shown a 
need for some kind of long-term maintenance therapy. However, 
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the effect of this varies between improvement and reactivation.28 
Phosphonoformate (trisodium phosphonoformate, foscarne sodium, 
Foscarnet) in another alternative to CMV treatment. 7 
AIDS patients with toxoplasmosis often respond to sulfadiazine 
and pyrimethamine. The cryptococcal disease tr~atment includes 
amphoterin B or flucytosine although relapses are frequent if 
discontinued. Acyclovir is used with mucotaneous H~rpes simplex 
virus and oral acyclovir is used to treat chronic Herpes zoster.6 
AIDS related tuberculosis is managed with ansamycin which has 
shown to prevent HIV replication in vitro.7 
GENERALIZED TREATMENT FOR AIDS 
To date, although various therapeutic drugs specific for the HIV 
infection are being evaluated, there is no cure for AIDS. So 
far, only one drug, the antiviral azidothymadine (AZT) gained 
limited FDA approval for the treatment of the HIV infection. 7 It 
has shown to be effective in decreasing the chances of recurrent 
opportunistic infections but only for a short time span.6,7 Its 
mode of action deals with it crossing the blood/brain barrier and 
preventing reverse transcriptase. If the dosage is too high, 
side effects include nausea and anemia.? 
Immune modulators such as interon, interleukin-2, thymic 
derivatives, inosine, pranobex, naltrexone and reticulose are 
being tested for its abilities to restore the immune system. 
However, these drugs may ~lso be very toxic.? 
A very recent study cloned a synthetic protein, CD4, in order to 
inhibit the action of the HIV virus. It was said to have 
stopped the growth of the virus completely in vitro. In its 
natural state, CD4 is found on the outside of T-cells. When the 
virus targets a cell, it attaches itself to the CD4 protein and 
infects the cell - a key step to infection. Therefore, the 
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synthetic CD4 serves to block direct infection from the free 
floating virus, impede giant cell formation/mass cell death and 
prevent the immune system from attacking healthy t-cell that 
"look" infected. However, this is only a small step towards a 
curative treatment. Because it is such a new idea, more studies 
need to be done on its side effects, activities and 
effectiveness.31 
To date, although there has been no evidence that suggest AIDS 
transmission thru the tears, conjunctiva, and cornea, we as 
primary health care professionals must maintain and practice 
office standards which decrease or eliminate the chances of 
contamination. Of utmost importance for the Opt~metrist, are 
the areas of contact lens fitting and routine optometric exam 
procedures.36 Listed below are recommendations and guidelines of 
the Food and Drug Administration (FDA), the National Institutes 
of Health (NIH) and CDC to help us avoid AIDS transmission.3 7 
CONTACT LENS FITTING 
TRIAL SOFT CONTACT LENSES 
Commercially available hydrogen peroxide (H2o2 ) contact lens 
disinfecting solution is the most commonly used method for the 
deactivation of the AIDS virus.36,37 Cleaning and boiling for 30 
minutes in fresh saline is also adequate for the disinfection of 
most low and high water content trial lenses.36,37 
TRIAL HARD CONTACT LENSES 
Although the chances of contamination with hard contacts are 
extremely low, surfactant cleaning and rinsing cannot guarantee 
complete disinfection.36 
Therefore, trial hard lenses can be treated with the same H2o2 
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system approved for soft contact lenses. Note: (Using an 
alternate H202 preparation could discolor the lenses due to 
preservatives).37,38 
Another method of treatment is the standard heat disinfection 
used for soft contact lenses at 70-so0 c (172-176°F) for 10 
minutes. 3 7 It would be a good idea though, tO'"' check with the 
hard contact lens supplier to see which lenses can be safely 
., 
heat-treated.37,38 
Alternately, the lenses can be rubbed with a 70% alcohol 
solution, rinsed and stored dry or in a sterile solution.36 
TRIAL RIGID GAS PERM CONTACT LENSES 
Rigid gas permeable (RGP) trial lenses can also be treated with 
the H2o2 system as above.38 Heat treatment is contraindicated as 
the RGP lens may warp.37 
Previously, only H202 and heat were the most effective in killing 
the virus. The only draw back of these two systems is that they 
are tedious and take up office time.7 
A recent study has shown that other chemical disinfection systems 
may be just as effective. Three in specific: Alcon's Opti-clean 
and Flex care; Allergan's LC-65 and Hydrocare; Barnes Hind's Soft 
Mate daily cleaner and disinfecting/storage solution were shown 
to greatly decrease or eliminate the virus infected lenses.7 
OPTOMETRIC EXAMINATION PROCEDURES 
HANDWASHING AND PROTECTIVE ACCESSORIES 
Any Optometrist who performs procedures which involve contact 
with tears should wash their hands immediately after the test and 
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between patients. Use of gloves are only indicated where there 
are open wounds or dermatological lesions on the hands. Masks, 
goggles or gowns are not necessary.36,38 
WORKING SURFACES 
Chin-, brow-, head- rests, refractor heads and areas used for 
contact lens fitting may represent sites for contamination.36 
Therefore, these areas along with containers that cannot be heat 
disinfected, should be wiped with a .2% or greater sodium 
hypochlorite solution or an alcohol solution (70% or more).36,38 
INSTRUMENTS 
Devices that directly contact the external surface of the eye 
such as the Goldmann tonometer prism, Goldmann .c;::ontact lens or 
schiotz tonometer should be wiped well and disinfected by either 
of the methods listed below. 38 ., 
a) 5-10 minute exposure to a fresh solution of 3% H2o2 .38 
b) A 1-10 dilution of fresh sodium-hypochlorite (common 
household bleach).37,38 
c) 70% ethanol or isopropanol. 
d) Soaked in a 2% glutaraldehyde for no more than 10 
minutes.37 
The instruments should then be rinsed thoroughly in tap water and 
dried before reuse.38 
ANESTHETICS AND EYE DROP SOLUTIONS 
Solutions which use the dropper for application have the risk of 
contamination if contacted with the tears or lashes of an 
infected patient. Chances of contamination can be eliminated 
by using single dose minims.36 
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TRIAL FRAMES AND SAMPLE SPECTACLES 
Trial frames can be disinfected using 70% alcohol, hypochlorite 
solutions or soap and water. However, it is highly unlikely that 
AIDS would be passed by such casual means.36 
DISPOSAL 
Proper disposal of contaminated strips, tissues and swabs should 
be enforced by all employees and employers. The use of crush 
proof and leakproof containers ·from which contents cannot be 
retrieved are recommended.36,41 
Other Optometric procedures which run the risk of infection and 
should be handled with care include: 
Foreign body removal 
Irrigation 
Schirmer test 
Corneal Sensitivity measurement (aesthesiometry) 
Strict adherence to these disinfection guidelines will prove 
beneficial for the Optometrist, patient and AIDS patient in that 
it will decrease the risk of potential infections and ensure good 
hygiene.36 
RESPONSIBILITIES OF THE OPTOMETRIST 
As primary health care providers, in addition to being good 
oberservers of the eye, we should go a step further and be able 
to evaluate the patient as a whole. This means recognizing 
non-ocular and behavioral signs. The AIDS patient may hesitate 
to reveal his symptoms in fear of discrimination and criticism or 
he may not be aware of or have any symptoms especially in the 
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early stages of the disease. 
In addition, the Optometrist must ask the appropiate questions 
during the case. For example, it is not sufficient for the 
clinician to ask whether the patient is on any medications. 
He/She should be more specific and ask whether any recreational 
drugs are being used. 
As with all patients, it is important that a good doctor-patient 
........ 
relationship be established. early on in order to build patient 
trust and confidence. However, this is especially true when 
dealing with AIDS patients since AIDS is such a sensitive issue. 
If a patient presents with any symptoms or signs indicative of 
AIDS we should refer him to the appropiate physician to ensure 
best possible care. 
Patient confidentiality is another issue to be addressed. The 
law regarding the confidentiality of medical records differ, 
depending on which state you practice in. Therefore, an 
Optometrist should contact the appropiate department to find out 
more information about where the state stands on this policy. 
If the Optometrist needs to obtain more information about AIDS, 
listed below are names and numbers of agencies to contact: 
1) CDC Hotline: 1-800-342-AIDS (recorded information) 
1-800-447-AIDS (specific questions) 
2) Atlanta: (404) 329-3534 (printed material) 
(404) 329-1290 (recorded information) 
(404) 329-1295 (specific questions) 
3) National Institute of Allergy and Infectious Diseases 
Office of Research reporting and Public response: 
(301) 496-5717 
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4) American Red Cross/AIDS Public Education Program: 
*Contact local chapter for information 
5) American Association of Physicians for Human rights (M.D. 
referrals) : 
P.O. Box 14366 
San Francisco, CA 94114 
(415) 673-3189 
6) National lesbian and Gay Health Foundation (Health Care 
referrrals): 
P.O. Box 65472 
Washington D.C. 20035 
(202) 797-3708 
7) National Association of People with AIDS: 
(202) 483-7979 
CONCLUSION 
The advent of AIDS is rightfully called the greatest public 
diaster of the century. Optometrists, as primary vision care 
specialists, have an obligation to understand this disease and to 
remain up-to-date with the latest technical and sociological 
developments. Only then can we provide the best possible care to 
the patients who seek our services through proper detection, 
prevention and education. At the root of these efforts we must 
ensure that at least in our professional capacity, we don't 
become vectors in the transmission of this dreadful disease. 
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